Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

CRH promotes fat production in skin cells, affecting conditions like acne.

A new model helps predict treatment success in girls with early puberty.

The skin produces and responds to thyroid-stimulating hormone, which is controlled by other thyroid-related hormones.

CRH in the skin acts like the body's stress response system, affecting cell behavior and immune activity.

TRH stimulates human hair growth and extends the hair growth phase.

Thyrotropin-Releasing Hormone helps heal wounds in frog and human skin.

Oestrogen and thyrotropin-releasing hormone affect prolactin and its receptor in human skin and hair, suggesting new treatment options for related conditions.

The nafarelin test can reliably distinguish between gonadotropin deficiency and delayed puberty in teenage boys.

Caffeine may help reduce stress-induced hair loss.

Higher CRHR1 levels in AA patients lead to increased inflammation.

CRH can cause hair loss by promoting cell death in hair growth cells.

Ganoderma lucidum extract may help treat stress-related hair loss.

The CRH/CRH-R1 system might be involved in causing lichen planus.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Growth hormone-releasing hormone (GHRH) boosts hair growth and human scalp hair follicles have their own growth hormone system.

Chronic GnRHa treatment can help manage endometrial hyperplasia and reduce ovarian androgen excess in PCO patients.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Researchers created a mouse model for Cushing's syndrome to study glucocorticoid excess and potential treatments.

The treatment successfully lowered testosterone levels and reduced symptoms.

Thyrotropin-releasing hormone may help control skin and hair growth and could aid in treating related disorders.

GnRH analogue can help diagnose ovarian causes of high testosterone in postmenopausal women when scans don't show the cause.

Goserelin and oestradiol treatment slightly improved hairiness but did not significantly change sebum production or hair characteristics in mildly hirsute women.

GnRH agonists can help manage recurrent priapism in sickle cell patients, but long-term safety is unclear.

CRH causes hair loss by reducing autophagy and increasing cell death in hair cells.

CRH causes hair loss by reducing cell survival in hair follicles.